Hiraga T - Search Results

1

Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.

Hiraga T, Kizaka-Kondoh S, Hirota K, Hiraoka M, Yoneda T. Hiraga T, et al. Cancer Res. 2007 May 1;67(9):4157-63. doi: 10.1158/0008-5472.CAN-06-2355. Cancer Res. 2007. PMID: 17483326

2

Use of bisphosphonates for the treatment of bone metastasis in experimental animal models.

Yoneda T, Michigami T, Yi B, Williams PJ, Niewolna M, Hiraga T. Yoneda T, et al. Among authors: hiraga t. Cancer Treat Rev. 1999 Oct;25(5):293-9. doi: 10.1053/ctrv.1999.0133. Cancer Treat Rev. 1999. PMID: 10544073 Review.

3

Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma.

Yoneda T, Michigami T, Yi B, Williams PJ, Niewolna M, Hiraga T. Yoneda T, et al. Among authors: hiraga t. Cancer. 2000 Jun 15;88(12 Suppl):2979-88. doi: 10.1002/1097-0142(20000615)88:12+<2979::aid-cncr13>3.0.co;2-u. Cancer. 2000. PMID: 10898341 Review.

4

Preclinical studies with zoledronic acid and other bisphosphonates: impact on the bone microenvironment.

Mundy GR, Yoneda T, Hiraga T. Mundy GR, et al. Among authors: hiraga t. Semin Oncol. 2001 Apr;28(2 Suppl 6):35-44. doi: 10.1016/s0093-7754(01)90263-5. Semin Oncol. 2001. PMID: 11346863 Review.

5

The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases.

Hiraga T, Williams PJ, Mundy GR, Yoneda T. Hiraga T, et al. Cancer Res. 2001 Jun 1;61(11):4418-24. Cancer Res. 2001. PMID: 11389070

6

A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro.

Yoneda T, Williams PJ, Hiraga T, Niewolna M, Nishimura R. Yoneda T, et al. Among authors: hiraga t. J Bone Miner Res. 2001 Aug;16(8):1486-95. doi: 10.1359/jbmr.2001.16.8.1486. J Bone Miner Res. 2001. PMID: 11499871 Free article.

7

The effect of the bisphosphonate ibandronate on breast cancer metastasis to visceral organs.

Michigami T, Hiraga T, Williams PJ, Niewolna M, Nishimura R, Mundy GR, Yoneda T. Michigami T, et al. Among authors: hiraga t. Breast Cancer Res Treat. 2002 Oct;75(3):249-58. doi: 10.1023/a:1019905111666. Breast Cancer Res Treat. 2002. PMID: 12353814

8

Bisphosphonate actions on cancer.

Yoneda T, Hashimoto N, Hiraga T. Yoneda T, et al. Among authors: hiraga t. Calcif Tissue Int. 2003 Oct;73(4):315-8. doi: 10.1007/s00223-002-0025-x. Epub 2003 Jul 24. Calcif Tissue Int. 2003. PMID: 12874704 Review.

9

Effects of oral UFT combined with or without zoledronic acid on bone metastasis in the 4T1/luc mouse breast cancer.

Hiraga T, Ueda A, Tamura D, Hata K, Ikeda F, Williams PJ, Yoneda T. Hiraga T, et al. Int J Cancer. 2003 Oct 10;106(6):973-9. doi: 10.1002/ijc.11330. Int J Cancer. 2003. PMID: 12918079

10

C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis.

Myoui A, Nishimura R, Williams PJ, Hiraga T, Tamura D, Michigami T, Mundy GR, Yoneda T. Myoui A, et al. Among authors: hiraga t. Cancer Res. 2003 Aug 15;63(16):5028-33. Cancer Res. 2003. PMID: 12941830

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters